Gene editing

Human CRISPR trial heralds Longevity success

Trial finds not only that gene-edited immune cells are safe, but that they survive and thrive after being placed into patients suffering from advanced...

Rejuvenate Bio teaches old dogs new tricks

A combination gene therapy developed by the Wyss Institute and Harvard Medical School is set to treat several age-related conditions in dogs, extending their...

23andMe redundancies: DNA test market decline?

Could layoffs at 23andMe be a sign that the consumer appetite for genetic testing is declining? We expect consumer markets to transition to more...

UK Gov releases human germline editing brief

Human Germline Genome Engineering is a highly controversial area – altering genes so that changes are passed on to all descendants.  Just because we...

Ageotype: Four new types of biomarker

You’ve obviously heard of stereotype. But how about an ageotype? Scientists have identified at least four types of aging, which could explain why we...

Healios bets on natural born killers

Healios is turning to natural killer cells (NK) to develop a range of new treatments which target solid tumours. Regenerative medicine innovator Healios KK has...

CRISPR in-body gene revolution gets underway

It has been an ethical minefield, but a scientific revolution. Could CRISPR in-body now be the next step in health span and lifespan therapies? Crispr...

Healios to fast-track pluripotent stem cell therapy

Healios K.K. to bring its novel regenerative pluripotent stem cell treatments to market through accelerated Japanese approvals process. Stem cell pioneers Healios KK will use...

Primetime for more powerful CRISPR tech

Researchers have developed a novel and more powerful form of CRISPR that offers the possibility to correct most disease-causing genetic variations in DNA  –...

Machine learning and fast track gene therapy

Following latest research at Harvard's Wyss Institute, a machine learning tool could be key to the future of gene therapy delivery. Gene therapies have long...

Exclusive: Interview with US presidential candidate

Zoltan Istvan to challenge Trump in 2020; solving Longevity is at the top of his agenda. Last week, the transhumanist activist Zoltan Istvan announced his...

Genetic discoveries: Implications for Longevity

New genetic discoveries suggest that components of the extracellular matrix might represent a link between immune defence and Longevity: Present and future directions. Even though...

Gene test predicts sudden cardiac death

Identification of rare DNA variants might flag up individuals at high risk of cardiac death before any symptoms appear. Globally, sudden and unexpected cardiac death...

Vertex/CRISPR therapy: Longevity landmark?

Could an exciting breakthrough in the treatment of blood disorders by gene editing hold the key to improving Longevity and delaying senescence? The first two...

Gene editing: “fear and excitement in equal measure”

Top lawyer highlights concerns raised by expected growth in gene editing sector. Earlier this year, a major US financial analyst firm identified Longevity as one...

Ervaxx exits stealth mode with $17.5 million

UK start-up Ervaxx targets 'dark matter' genes to develop cell therapies. After two years in stealth mode, the new UK-based start-up Ervaxx has stepped out of...

Prime editing set to take slice from CRISPR

Better than CRISPR? A new prime-editing tool could  correct 89% of the known human genetic variants and be more accurate and versatile than CRISPR. Enter...

Hacking Longevity: Exclusive with Jamie Metzl

Jamie Metzl is a technology and healthcare futurist and geopolitical expert, novelist, entrepreneur, media commentator, and Senior Fellow of the Atlantic Council. In February 2019,...

Researchers pin Longevity hopes on new CRISPR gene editor

$34M in new Trucode funding could challenge CRISPR gene editing domination of genetic engineering market. Have we reached the thin end of the CRISP? For...

Genetic biomarkers for Longevity discovered

International research group finds 17 different genetic interventions that extend life. Researchers in Moscow and Harvard have been able to identify a group of genes...

Latest articles

Longevity 2020: shaping-up nicely

Over 45 confirmed speakers for this 5-day online event and a big thank you for your interest. We're moving fast! Longevity 2020 started just over...

Telomeres on repeat to inhibit inflamm-aging

Coming around again – Italian team hopes to use repeated nucleobases to delay aging through extending telomeres. Inflammation is a double-edged sword; while it is necessary...

Join me at my 100th birthday party in 2049!

We speak with GRG's Johnny Adams, a key contributor to the Longevity2020 online conference, about his quest for more healthy years. One of the speakers at this month’s...

Call for consensus in defining biological aging

We speak with a key contributor to the Longevity2020 online conference about biological aging. UK start-up AgeCurve is focused on the measurement of aging and...

Sign-up for daily news on the research, investments and technologies driving the Longevity market.

Sign-up for daily news on the research, investments and technologies driving the Longevity market.